Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Helfand

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
Urology|February 1, 2025
Editorial Comment on "Robotic Waterjet Resection for Men With Prostate Cancer Suffering From Lower Urinary Tract Symptoms"Greg Raster, Brian T Helfand
The Urologic Clinics of North America|July 2, 2021
Germline Testing for Prostate Cancer Prognosis: Implications for Active SurveillanceBrian T Helfand, Jianfeng Xu
The Journal of Urology|May 17, 2019
Editorial CommentCraig Labbate, Brian T Helfand
The Journal of Urology|October 4, 2019
Editorial CommentJianfeng Xu, Brian T Helfand
Current Urology Reports|July 12, 2023
Is Active Surveillance Too Active?James T Kearns, Brian T Helfand
Urology|January 2, 2019
AUTHOR REPLYRichard J Fantus, Brian T Helfand
The Journal of Urology|September 9, 2020
Editorial CommentBrian T Helfand, Alexander P Glaser
Clinical Chemistry|November 22, 2018
Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection ToolsRichard J Fantus, Brian T Helfand
The Urologic Clinics of North America|April 15, 2014
The epidemiology and clinical implications of genetic variation in prostate cancerBrian T Helfand, William J Catalona
BJU International|March 13, 2016
To PSA or not to PSA? Still a question for men with a family history of prostate cancerChristina G Selkirk, Brian T Helfand
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
Urology|February 1, 2025
Editorial Comment on "Robotic Waterjet Resection for Men With Prostate Cancer Suffering From Lower Urinary Tract Symptoms"Greg Raster, Brian T Helfand
The Urologic Clinics of North America|July 2, 2021
Germline Testing for Prostate Cancer Prognosis: Implications for Active SurveillanceBrian T Helfand, Jianfeng Xu
The Journal of Urology|May 17, 2019
Editorial CommentCraig Labbate, Brian T Helfand
The Journal of Urology|October 4, 2019
Editorial CommentJianfeng Xu, Brian T Helfand
Current Urology Reports|July 12, 2023
Is Active Surveillance Too Active?James T Kearns, Brian T Helfand
Urology|January 2, 2019
AUTHOR REPLYRichard J Fantus, Brian T Helfand
The Journal of Urology|September 9, 2020
Editorial CommentBrian T Helfand, Alexander P Glaser
Clinical Chemistry|November 22, 2018
Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection ToolsRichard J Fantus, Brian T Helfand
The Urologic Clinics of North America|April 15, 2014
The epidemiology and clinical implications of genetic variation in prostate cancerBrian T Helfand, William J Catalona
BJU International|March 13, 2016
To PSA or not to PSA? Still a question for men with a family history of prostate cancerChristina G Selkirk, Brian T Helfand
Pageof 25